NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8600
-0.0420 (-4.66%)
At close: Mar 28, 2025, 4:00 PM
0.8979
+0.0379 (4.41%)
After-hours: Mar 28, 2025, 7:57 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $3.27M in the quarter ending December 31, 2024, with 234.90% growth. This brings the company's revenue in the last twelve months to $5.75M, up 104.21% year-over-year. In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth.
Revenue (ttm)
$5.75M
Revenue Growth
+104.21%
P/S Ratio
4.26
Revenue / Employee
$338,207
Employees
17
Market Cap
26.54M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNMTC News
- 10 days ago - NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update - GlobeNewsWire
- 11 days ago - NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - GlobeNewsWire
- 11 days ago - NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - GlobeNewsWire
- 18 days ago - NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 24 days ago - NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 6 weeks ago - NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time - GlobeNewsWire